4.4 Article

Interferon-γ Involvement in the Neuroinflammation Associated with Parkinson's Disease and L-DOPA-Induced Dyskinesia

Journal

NEUROTOXICITY RESEARCH
Volume 39, Issue 3, Pages 705-719

Publisher

SPRINGER
DOI: 10.1007/s12640-021-00345-x

Keywords

Parkinson’ s disease; Astrocytes; Microglia; IFN-γ Dyskinesia

Categories

Funding

  1. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
  2. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/25029-4]
  3. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [402658/2012-4]
  4. FAPESP fellowship [2017/14419-4]

Ask authors/readers for more resources

The absence of IFN-gamma intensifies the inflammatory reaction during L-DOPA treatment, but does not affect the degeneration of dopaminergic neurons or LID development.
Interferon-gamma (IFN-gamma) is a proinflammatory cytokine that activates glial cells. IFN-gamma is increased in the plasma and brain of Parkinson's disease patients, suggesting its potential role in the disease. We investigated whether the IFN-gamma deficiency could interfere with nigrostriatal degeneration induced by the neurotoxin 6-hydroxydopamine, L-DOPA-induced dyskinesia, and the neuroinflammatory features as astrogliosis, microgliosis, and induced nitric oxide synthase (iNOS) immunoreactivity induced by L-DOPA treatment. Wild type (WT) and IFN-gamma knockout (IFN-gamma/KO) mice received unilateral striatal microinjections of 6-hydroxydopamine. Animals were sacrificed 1, 3, 7, and 21 days after lesions. Additional group of WT and IFN-gamma/KO parkinsonian mice, after 3 weeks of neurotoxin injection, received L-DOPA (intraperitoneally, for 21 days) resulting in dyskinetic-like behavior. Tyrosine hydroxylase immunostaining indicated the starting of dopaminergic lesion since the first day past toxin administration, progressively increased until the third day when it stabilized. There was no difference in the lesion and L-DOPA-induced dyskinesia intensity between WT and IFN-gamma/KO mice. Remarkably, IFN-gamma/KO mice treated with L-DOPA presented in the lesioned striatum an increase of iNOS and glial fibrilary acid protein (GFAP) density, compared with the WT group. Morphological analysis revealed the rise of astrocytes and microglia reactivity in IFN-gamma/KO mice exibiting dyskinesia. In conclusion, IFN-gamma/KO mice presented an intensification of the inflammatory reaction accompanying L-DOPA treatment and suggest that iNOS and GFAP increase, and the activation of astrocytes and microglia induced afterward L-DOPA treatment was IFN-gamma independent events. Intriguingly, IFN-gamma absence did not affect the degeneration of dopaminergic neurons or LID development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available